Avalon Investment & Advisory Sanofi Transaction History

Avalon Investment & Advisory

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 17, 2022	SELL	$48.48 - $53.65 $264,943 - $293,197	-5,465 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$47.07 - $52.35 $117,016 - $130,142	-2,486 Reduced 31.27%	5,465 $274,000
Q3 2021 Nov 08, 2021	SELL	$47.89 - $53.12 $51,577 - $57,210	-1,077 Reduced 11.93%	7,951 $383,000
Q2 2021 Jul 29, 2021	SELL	$49.36 - $54.25 $69,350 - $76,221	-1,405 Reduced 13.47%	9,028 $475,000
Q1 2021 May 13, 2021	SELL	$45.46 - $50.51 $99,921 - $111,020	-2,198 Reduced 17.4%	10,433 $516,000
Q4 2020 Feb 08, 2021	BUY	$45.3 - $51.62 $43,850 - $49,968	968 Added 8.3%	12,631 $614,000
Q3 2020 Nov 04, 2020	BUY	$49.47 - $53.77 $44,176 - $48,016	893 Added 8.29%	11,663 $585,000
Q2 2020 Aug 07, 2020	BUY	$42.91 - $52.5 $15,962 - $19,530	372 Added 3.58%	10,770 $550,000
Q1 2020 May 05, 2020	BUY	$38.02 - $51.66 $395,331 - $537,160	10,398 New	10,398 $455,000

822

268M

1.9M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $120B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of Avalon Investment & Advisory, based on Form 13F filings with the SEC.

Stay updated on Avalon Investment & Advisory with notifications on news.